Fabio
5.5 KiB
5.5 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Office-based buprenorphine treatment; Board of Medicine to amend regulations. | Board of Medicine; office-based buprenorphine treatment; counseling. Directs the Board of Medicine to amend its regulations regarding office-based buprenorphine treatment to require providers to offer counseling or referral to counseling to each patient as clinically necessary and mutually agreed-upon. The bill specifies that a patient's refusal of counseling does not preclude the patient from receiving office-based buprenorphine treatment for opioid use disorder. This bill is a recommendation of the Joint Commission on Health Care and is identical to HB 712. | us/states/va | Virginia General Assembly | 2026 | SB 641 | Virginia SB 641 (2026) |
|
enacted |
|
3 | 28 | 5 | 2026-01-14 | 2026-04-06 | openstates | ocd-bill/4520cc5a-9cc5-4aa5-9999-24601a13051b | https://lis.virginia.gov/bill-details/20261/SB641 | 33770c1f8a2e5f57724a49fd836c31d29bcd97172670a2608d8df71a02e51836 | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Virginia SB 641 (2026) — Office-based buprenorphine treatment; Board of Medicine to amend regulations.
Board of Medicine; office-based buprenorphine treatment; counseling. Directs the Board of Medicine to amend its regulations regarding office-based buprenorphine treatment to require providers to offer counseling or referral to counseling to each patient as clinically necessary and mutually agreed-upon. The bill specifies that a patient's refusal of counseling does not preclude the patient from receiving office-based buprenorphine treatment for opioid use disorder. This bill is a recommendation of the Joint Commission on Health Care and is identical to HB 712.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
Votes
- Passage R — 40–0 (pass) · upper
- Reported from Education and Health — 14–0 (pass) · upper
- Constitutional reading dispensed R — 39–0 (pass) · upper
- H VOTE: — 98–0 (pass) · lower
- Reported from Health and Human Services — 21–0 (pass) · lower
Sponsors
- Todd E. Pillion — primary (person)
- Bryce E. Reeves — cosponsor (person)
- Christie New Craig — cosponsor (person)
- Glen H. Sturtevant, Jr. — cosponsor (person)
- Luther Cifers, III — cosponsor (person)
- Mark D. Obenshain — cosponsor (person)
- Mark J. Peake — cosponsor (person)
- Richard H. Stuart — cosponsor (person)
- Ryan T. McDougle — cosponsor (person)
- T. Travis Hackworth — cosponsor (person)
- Tammy Brankley Mulchi — cosponsor (person)
- Timmy French — cosponsor (person)
- William M. Stanley, Jr. — cosponsor (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2026-01-14 Prefiled and ordered printed; Offered 01-14-2026 26104754D
filing, introduction - 2026-01-14 Referred to Committee on Education and Health
referral-committee - 2026-01-21 Fiscal Impact Statement from Department of Planning and Budget (SB641)
- 2026-01-30 Assigned Education sub: Health Professions
referral-committee - 2026-02-05 Reported from Education and Health (14-Y 0-N)
committee-passage - 2026-02-06 Rules suspended
- 2026-02-06 Constitutional reading dispensed (on 1st reading) (39-Y 0-N 0-A)
- 2026-02-06 Passed by for the day (Voice Vote)
- 2026-02-06 Passed by for the day
- 2026-02-09 Read second time
reading-2 - 2026-02-09 Engrossed by Senate (Voice Vote)
- 2026-02-10 Read third time and passed Senate (40-Y 0-N 0-A)
passage, reading-3 - 2026-02-13 Placed on Calendar
- 2026-02-13 Read first time
reading-1 - 2026-02-13 Referred to Committee on Health and Human Services
referral-committee - 2026-02-19 Reported from Health and Human Services (21-Y 0-N)
committee-passage - 2026-02-23 Read second time
reading-2 - 2026-02-24 Read third time
reading-3 - 2026-02-24 Passed House (98-Y 0-N 0-A)
passage - 2026-02-26 Enrolled
enrolled - 2026-02-26 Bill text as passed Senate and House (SB641ER)
passage - 2026-02-26 Signed by Speaker
passage - 2026-02-26 Signed by President
passage - 2026-03-02 Fiscal Impact statement From DPB (3/2/2026 2:20 pm)
- 2026-03-10 Enrolled Bill communicated to Governor on March 10, 2026
enrolled, executive-receipt - 2026-03-10 Governor's Action Deadline 11:59 p.m., April 13, 2026
executive-receipt - 2026-04-06 Approved by Governor-Chapter 208 (effective 7/1/2026)
executive-signature - 2026-04-06 Acts of Assembly Chapter text (CHAP0208)
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/4520cc5a-9cc5-4aa5-9999-24601a13051b. Confidence: reported (aggregated from official Virginia legislature records).